|
HividDrug - Hivid The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Zalcitabine
Strength -
0.75MG
Applicant -
ROCHE
New Drug Application (NDA) Number -
020199
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 19, 1992
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Hoffmann La Roche Inc
Hivid
Xenon Xe 133-v.S.S. 10mci/vial Gas; Inhalation
Xenon Xe 133 6.3mci/ml Injectable; Injection Xenon Xe 133 1.3-1.7 Ci/amp Injectable; Injection Xeneisol 18-25mci/amp Solution; Inhalation, Injection Xylo-pfan 25gm/bot Powder; Oral Xylose 25gm/bot Powder; Oral Accolate 10mg Tablet; Oral Accolate 20mg Tablet; Oral Hivid 0.375mg Tablet; Oral Hivid 0.75mg Tablet; Oral NewDrugInformation |